CURRENT PHARMACEUTICAL BIOTECHNOLOGY, vol.21, pp.710-719, 2020 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Coronary bypass, anacardic acid, saphenous vein, atherosclerosis, inflammation, NF-kappa B, NF-KAPPA-B, CORONARY-ARTERY-BYPASS, AMYLOID-BETA 1-42, ADHESION MOLECULES, ICAM-1 EXPRESSION, INDUCED VCAM-1, GRAFT, PATHOGENESIS, INHIBITION, ACTIVATION
Background and Objective: Coronary bypass operations are commonly performed for the treatment of ischemic heart diseases. Coronary artery bypass surgery with autologous human saphenous vein maintains its importance as a commonly used therapy for advanced atherosclerosis. Vascular inflammation-related intimal hyperplasia and atherosclerotic progress have major roles in the pathogenesis of saphenous vein graft disease.